Polyamyna

About:

Polyamyna develops advanced antimicrobial technologies to combat multi-extensive and pan-drug-resistant pathogenic microorganisms.

Website: https://www.polyamyna.ca/

Twitter/X: polyamyna

Top Investors: Government of Newfoundland and Labrador, Sustainable Development Technology Canada, National Research Council of Canada Industrial Research Assistance Program, Genesis

Description:

Polyamyna helps to develop next-generation antimicrobial technologies to prevent infections caused by deadly pathogens, especially ESKAPE bacteria. Their products includes advanced antimicrobial technologies and disinfectant technology. Their customer can contact them through online.

Total Funding Amount:

$1.73M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

St. John's, Newfoundland, Canada

Founded Date:

2017-01-01

Founders:

Kishan Gorityala, Ramesh Kumar Mani

Number of Employees:

11-50

Last Funding Date:

2023-09-05

IPO Status:

Private

Industries:

© 2025 bioDAO.ai